Atypical mycobacterial cervicofacial lymphadenitis in children: a disease as old as mankind, yet a persistent

Adele Karen Evans1, Michael J Cunningham

  • 1Department of Otology and Laryngology, Harvard Medical School, Boston, MA, USA.

Insights

Diagnosing atypical cervicofacial lymphadenitis in children can be challenging. Early identification of mycobacterial causes is crucial to prevent misdiagnosis and ensure timely treatment for this neck lymph node infection.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Clinical Diagnostics

Background:

  • Atypical cervicofacial lymphadenitis in children often presents with non-specific symptoms, delaying clinical diagnosis.
  • Accurate etiological determination (viral, bacterial, or mycobacterial) is essential for appropriate management.
  • Distinguishing between atypical and tuberculous mycobacterial infections is critical for targeted therapy.

Observation:

  • Children with acute-onset cervicofacial lymphadenitis may present to physicians before classic signs develop.
  • Clinical assessment must differentiate between various infectious agents causing lymphadenitis.
  • Mycobacterial etiology requires further classification into typical or atypical forms.

Findings:

  • This review focuses on the evaluation, diagnosis, and management of cervicofacial lymphadenitis caused by atypical mycobacteria in pediatric patients.
  • Case studies illustrate the diagnostic challenges and therapeutic approaches for these infections.
  • Early recognition of atypical mycobacterial lymphadenitis is key to effective treatment.

Implications:

  • Improved diagnostic strategies can reduce the duration of symptoms and prevent misdiagnosis.
  • Timely and accurate diagnosis leads to appropriate antimicrobial therapy, improving patient outcomes.
  • Understanding the nuances of atypical mycobacterial infections is vital for pediatricians and infectious disease specialists.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...